MedTrace Logo

Study of Hydrogen-rich Water Compared With Placebo in Type 2 Diabetes Patients

NCT05905588 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 96

Last updated 2023-06-15

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy and safety of hydrogen-rich water in type 2 diabetes patients.

Conditions

Interventions

DIETARY_SUPPLEMENT

Hydrogen-rich water

Patients drink 600mL hydrogen-rich water per day by applying hydrogen-rich water cup (Qingdao Haizhisheng Corp.,LTD, Qingdao, China) for 12 weeks. The dissolved hydrogen concentration is 5 ppm.

DIETARY_SUPPLEMENT

placebo

Patients drink 600mL tap water per day by applying analogue cup for 12 weeks. This cup has the same appearance as the hydrogen-rich water cup, and the hydrogen-rich water and placebo water were indistinguishable. The dissolved hydrogen concentration is 0 ppm in placebo water.

Sponsors & Collaborators

  • Qingdao Hiser Medical Group

    collaborator OTHER

  • Qingdao University

    lead OTHER

Principal Investigators

  • Tongshang Ni, Ph.D · Qingdao Universtiy

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-01
Primary Completion
2023-08-31
Completion
2023-08-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05905588 on ClinicalTrials.gov